M. Talebi

发表

J. Bernatonienė, T. Farkhondeh, S. Samarghandian, 2021, Molecules.

T. Farkhondeh, S. Samarghandian, M. Talebi, 2020 .

T. Farkhondeh, S. Samarghandian, M. Talebi, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

P. Tarantilis, E. Kakouri, T. Farkhondeh, 2021, International journal of biological macromolecules.

M. Ashrafizadeh, T. Farkhondeh, Babak Roshanravan, 2020, Archives of physiology and biochemistry.

J. Simal-Gándara, J. Bernatonienė, T. Farkhondeh, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

T. Farkhondeh, S. Samarghandian, M. Talebi, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A. Khamesipour, M. Mohebali, K. Kamyab, 2015, Iranian journal of parasitology.

T. Farkhondeh, S. Samarghandian, M. Talebi, 2020, Phytotherapy research : PTR.

T. Farkhondeh, S. Samarghandian, M. Talebi, 2022, Revista Brasileira de Farmacognosia.

G. Mishra, T. Farkhondeh, S. Samarghandian, 2021, Phytotherapy research : PTR.

J. Simal-Gándara, J. Bernatonienė, T. Farkhondeh, 2021, Cancer cell international.

T. Farkhondeh, S. Samarghandian, A. Pourbagher-Shahri, 2022, Behavioral and Brain Functions.

M. Shakibaei, M. Ashrafizadeh, T. Farkhondeh, 2021, Molecules.

P. Tarantilis, E. Kakouri, T. Farkhondeh, 2021, Expert review of neurotherapeutics.

M. Ashrafizadeh, T. Farkhondeh, A. Pourbagher-Shahri, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

M. Talebi, Vahideh Tarhriz, Haleh Forouhandeh, 2022, Journal of Reports in Pharmaceutical Sciences.

S. Samarghandian, M. Talebi, Mohsen Talebi, 2020, Biointerface Research in Applied Chemistry.

M. Shakibaei, M. Ashrafizadeh, S. Llorens, 2020, Molecules.

H. Esmaeeli, T. Farkhondeh, S. Samarghandian, 2021, Current pharmaceutical biotechnology.

S. A. Ayatollahi, Z. Ali, I. Khan, 2023, Pharmacological Research - Modern Chinese Medicine.

T. Farkhondeh, S. Samarghandian, M. Talebi, 2022, Current molecular pharmacology.

J. Simal-Gándara, J. Bernatonienė, T. Farkhondeh, 2021, Current drug targets.